185 related articles for article (PubMed ID: 38554167)
1. Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth.
Wilkinson AN; Chen R; Coleborn E; Neilson T; Le K; Bhavsar C; Wang Y; Atluri S; Irgam G; Wong K; Yang D; Steptoe R; Wu SY
Cancer Immunol Immunother; 2024 Mar; 73(5):80. PubMed ID: 38554167
[TBL] [Abstract][Full Text] [Related]
2. CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
K Au K; Peterson N; Truesdell P; Reid-Schachter G; Khalaj K; Ren R; Francis JA; Graham CH; Craig AW; Koti M
Gynecol Oncol; 2017 Jun; 145(3):436-445. PubMed ID: 28318643
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of microRNA let-7i depresses maturation and functional state of dendritic cells in response to lipopolysaccharide stimulation via targeting suppressor of cytokine signaling 1.
Zhang M; Liu F; Jia H; Zhang Q; Yin L; Liu W; Li H; Yu B; Wu J
J Immunol; 2011 Aug; 187(4):1674-83. PubMed ID: 21742974
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
Yang N; Kaur S; Volinia S; Greshock J; Lassus H; Hasegawa K; Liang S; Leminen A; Deng S; Smith L; Johnstone CN; Chen XM; Liu CG; Huang Q; Katsaros D; Calin GA; Weber BL; Bützow R; Croce CM; Coukos G; Zhang L
Cancer Res; 2008 Dec; 68(24):10307-14. PubMed ID: 19074899
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles-encapsulated let-7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis.
Liu J; Feng Y; Zeng X; He M; Gong Y; Liu Y
J Cell Mol Med; 2021 Feb; 25(4):1911-1926. PubMed ID: 33350586
[TBL] [Abstract][Full Text] [Related]
7. Propofol induces apoptosis of epithelial ovarian cancer cells by upregulation of microRNA let-7i expression.
Su Z; Hou XK; Wen QP
Eur J Gynaecol Oncol; 2014; 35(6):688-91. PubMed ID: 25556276
[TBL] [Abstract][Full Text] [Related]
8. A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.
Koti M; Siu A; Clément I; Bidarimath M; Turashvili G; Edwards A; Rahimi K; Mes-Masson AM; Squire JA
Br J Cancer; 2015 Mar; 112(7):1215-22. PubMed ID: 25826225
[TBL] [Abstract][Full Text] [Related]
9. CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer.
Yang M; Lu J; Zhang G; Wang Y; He M; Xu Q; Xu C; Liu H
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452206
[TBL] [Abstract][Full Text] [Related]
10.
Chirshev E; Suzuki T; Wang H; Nguyen A; Hojo N; Sanderman L; Mirshahidi S; Ioffe YJ; Unternaehrer JJ
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572843
[TBL] [Abstract][Full Text] [Related]
11. Morphology and tumour-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival.
Darb-Esfahani S; Kolaschinski I; Trillsch F; Mahner S; Concin N; Vergote I; Van Nieuwenhuysen E; Achimas-Cadariu P; Glajzer J; Woopen H; Wienert S; Taube ET; Stanske M; Kulbe H; Denkert C; Sehouli J; Braicu EI
Histopathology; 2018 Dec; 73(6):1002-1012. PubMed ID: 30007074
[TBL] [Abstract][Full Text] [Related]
12. STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer.
Ghaffari A; Peterson N; Khalaj K; Vitkin N; Robinson A; Francis JA; Koti M
Br J Cancer; 2018 Aug; 119(4):440-449. PubMed ID: 30046165
[TBL] [Abstract][Full Text] [Related]
13. The peritoneal tumour microenvironment of high-grade serous ovarian cancer.
Leinster DA; Kulbe H; Everitt G; Thompson R; Perretti M; Gavins FN; Cooper D; Gould D; Ennis DP; Lockley M; McNeish IA; Nourshargh S; Balkwill FR
J Pathol; 2012 Jun; 227(2):136-45. PubMed ID: 22322968
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis.
Lai NS; Yu HC; Chen HC; Yu CL; Huang HB; Lu MC
Clin Exp Immunol; 2013 Jul; 173(1):47-57. PubMed ID: 23607629
[TBL] [Abstract][Full Text] [Related]
15. Tumor extracellular vesicles loaded with exogenous Let-7i and miR-142 can modulate both immune response and tumor microenvironment to initiate a powerful anti-tumor response.
Khani AT; Sharifzad F; Mardpour S; Hassan ZM; Ebrahimi M
Cancer Lett; 2021 Mar; 501():200-209. PubMed ID: 33220334
[TBL] [Abstract][Full Text] [Related]
16. Profile of differentially expressed miRNAs in high-grade serous carcinoma and clear cell ovarian carcinoma, and the expression of miR-510 in ovarian carcinoma.
Zhang X; Guo G; Wang G; Zhao J; Wang B; Yu X; Ding Y
Mol Med Rep; 2015 Dec; 12(6):8021-31. PubMed ID: 26497752
[TBL] [Abstract][Full Text] [Related]
17. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal.
Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
Immunobiology; 2012 May; 217(5):533-9. PubMed ID: 21899916
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA let-7i induced autophagy to protect T cell from apoptosis by targeting IGF1R.
Hou C; Zhu M; Sun M; Lin Y
Biochem Biophys Res Commun; 2014 Oct; 453(4):728-34. PubMed ID: 25305490
[TBL] [Abstract][Full Text] [Related]
19. Reversal of paclitaxel resistance in epithelial ovarian carcinoma cells by a MUC1 aptamer-let-7i chimera.
Liu N; Zhou C; Zhao J; Chen Y
Cancer Invest; 2012 Oct; 30(8):577-82. PubMed ID: 22812695
[TBL] [Abstract][Full Text] [Related]
20. Propofol promotes apoptosis of colorectal cancer cells via alleviating the suppression of lncRNA HOXA11-AS on miRNA let-7i.
Ren YL; Zhang W
Biochem Cell Biol; 2020 Apr; 98(2):90-98. PubMed ID: 31013434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
